Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
The RESTORE trial: What did we learn about multiple sclerosis?
Transfer of central nervous system autoantigens and presentation in secondary lymphoid organs.
Recognition performance differentiates between elderly patients in the long term course of secondary progressive multiple sclerosis and amnestic mild cognitive impairment.
Promoting remyelination for the treatment of multiple sclerosis: opportunities and challenges.
Core muscle characteristics during walking of patients with multiple sclerosis.
Comprehensive Identification of Long Non-coding RNAs in Purified Cell Types from the Brain Reveals Functional LncRNA in OPC Fate Determination.
Efficacy and Safety of Fingolimod in an Unselected Patient Population.
Exclusive use of alternative medicine as a positive choice: a qualitative study of treatment assumptions among people with multiple sclerosis in denmark.
A Swiss real world best practice experience in three different clinical settings of the 6 hour fingolimod first dose observation procedure.
HLA associations in South Asian multiple sclerosis.
Impaired sleep-associated modulation of post-exercise corticomotor depression in multiple sclerosis.
Blood cells and endothelial barrier function.
Early silent microstructural degeneration and atrophy of the thalamocortical network in multiple sclerosis.
Detection of B-cell populations with monotypic light chain expression in cerebrospinal fluid specimens from patients with multiple sclerosis by polychromatic flow cytometry.
Epilepsy surgery outcome in temporal lobe cavernoma and multiple sclerosis.
Direct and indirect affection of the central nervous system by Fasciola infection.
Neurological disorders: Differential methylation in multiple sclerosis.
Robust Non-Local Multi-Atlas Segmentation of the Optic Nerve.
Juvenile myoclonic epilepsy with multiple sclerosis: Is there a dual role for valproate?
Dock3 protects myelin in the cuprizone model for demyelination.
[A review of multiple sclerosis (1). Presentation of a case.]
Melatonin Lulling Th17 Cells to Sleep.
Prorating WAIS-IV Summary Scores for Patients with Relapsing-Remitting Multiple Sclerosis.
Myelin-specific T cells induce interleukin-1beta expression in lesion-reactive microglial-like cells in zones of axonal degeneration.
A Case Report of Post Rabipur (Purified Chick Embryo Rabies Vaccine) Acute Disseminated Encephalomyelitis.
Pages
« first
‹ previous
…
410
411
412
413
414
415
416
417
418
…
next ›
last »